In vivo studies also showed that antitumor immunity induced by an HSP105 DNA vaccine could be used for immunotherapy or prevention of various human tumors overexpressing HSP105, including colorectal cancer and melanoma [6]. This evidence concerns the gene HSPH1 and colorectal cancer.